Considerations For Migrating A Drug Product Presentation From Vial To Pre-Filled Syringe
By Martin Gonzalez, Ph.D., Sr. Manager Formulation and Process Development, Pfizer CentreOne

        access the Article!
        
            Log In
        
    
    
    
    Get unlimited access to:
            Trend and Thought Leadership Articles
            
        
        
            Case Studies & White Papers
            
        
        
            Extensive Product Database
            
        
        
            Members-Only Premium Content
            
        
    
        Welcome Back! Please Log In to Continue.
        
            X
        
    
    Enter your credentials below to log in. Not yet a member of Biosimilar Development? Subscribe today.
        Subscribe to Biosimilar Development
        X
    
    
        Subscribe to Biosimilar Development